Document Detail


Elevated serum levels of high mobility group box protein 1 (HMGB1) in patients with ankylosing spondylitis and its association with disease activity and quality of life.
MedLine Citation:
PMID:  23143556     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
This study was carried out to determine the serum levels of high mobility group box protein 1 (HMGB1) in patients with ankylosing spondylitis (AS) and to evaluate its correlation with disease activity and quality of life. According to our knowledge, it is the first trial evaluating HMGB1 levels in AS. Serum samples of 30 patients (18 males and 12 females) with AS and 29 healthy controls (HC) (15 females and 14 males) were collected. HMGB1 levels were measured by enzyme-linked immunosorbent assay, activity of disease was assessed according to the Bath AS Disease Activity Index (BASDAI), and functional status of patients was evaluated with Bath AS Functional Index (BASFI). Modified Schober, chest expansion values and AS Quality of Life Questionnaire (ASQoL) scores were noted. The serum levels of HMGB1 were obtained significantly increased in AS patients compared to HC (p < 0.05). There was no significant correlation between HMGB1 levels and ESR (p > 0.05), and CRP (p > 0.05) values. BASDAI, BASFI and ASQoL scores were also not correlated with serum levels of HMGB1 (p > 0.05). Our results suggest that HMGB1 might play an important role in the pathogenesis of AS; however, it seems not to be a good candidate for reflecting disease activity, functional abilities and the quality of life in patients with AS; on the other hand, the increased levels of HMGB1 in patients may open a new dimension for targeting this cytokine as a new therapy option in AS.
Authors:
Pelin Oktayoglu; Serda Em; Mehmet Tahtasiz; Mehtap Bozkurt; Demet Ucar; Levent Yazmalar; Kemal Nas; Ibrahim Yardımeden; Figen Cevik; Yusuf Celik; Nuriye Mete
Related Documents :
23754356 - Th1/th2 cytokines in patients with graves' disease with or without ophthalmopathy.
23330596 - The clinicopathological spectrum and management of intraductal papillary mucinous neopl...
23406826 - Resistance-associated amino acid variants associated with boceprevir plus pegylated int...
23916526 - Progression of low-grade dysplasia to advanced neoplasia based on the location and morp...
2770356 - Evaluation of leg edema using a multifrequency impedance meter in patients with lymphat...
9100046 - High c-reactive protein is a strong predictor of resistance to erythropoietin in hemodi...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-10
Journal Detail:
Title:  Rheumatology international     Volume:  -     ISSN:  1437-160X     ISO Abbreviation:  Rheumatol. Int.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8206885     Medline TA:  Rheumatol Int     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Dicle University, Diyarbakir, Turkey, plnftr@hotmail.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of cyclophosphamide on cytokines in patients with primary Sjögren's syndrome-associated inte...
Next Document:  Bisphosphonates or prostacyclin in the treatment of bone-marrow oedema syndrome of the knee and foot...